Skip to main content

15 Result(s)

within Karin Weissenborn Remove this filter Metabolic Diseases Remove this filter

and

  1. No Access

    Article

    Qualifying and quantifying minimal hepatic encephalopathy

    Minimal hepatic encephalopathy is the term applied to the neuropsychiatric status of patients with cirrhosis who are unimpaired on clinical examination but show alterations in neuropsychological tests explorin...

    Marsha Y. Morgan, Piero Amodio, Nicola A. Cook, Clive D. Jackson… in Metabolic Brain Disease (2016)

  2. No Access

    Article

    Psychometric tests for diagnosing minimal hepatic encephalopathy

    While it is consensus that minimal hepatic encephalopathy (mHE) has significant impact on a patient’s daily living, and thus should be diagnosed and treated, there is no consensus about the optimal diagnostic ...

    Karin Weissenborn in Metabolic Brain Disease (2013)

  3. Article

    Introduction

    Michael P. Manns, Karin Weissenborn in Metabolic Brain Disease (2010)

    Download PDF (41 KB) View Article

  4. No Access

    Article

    Hepatitis C virus infection and the brain

    There is growing evidence that hepatitis C virus (HCV)-infection may affect the brain. About half of the HCV-infected patients complain of chronic fatigue irrespective of their stage of liver disease or virus ...

    Karin Weissenborn, Anita B. Tryc, Meike Heeren, Hans Worthmann… in Metabolic Brain Disease (2009)

  5. No Access

    Article

    Introduction

    Karin Weissenborn, Michael P. Manns in Metabolic Brain Disease (2007)

  6. No Access

    Article

    The treatment of hepatic encephalopathy

    Current recommendations for the treatment of hepatic encephalopathy are based, to a large extent, on open or uncontrolled trials, undertaken in very small numbers of patients. In consequence, there is ongoing ...

    Marsha Y. Morgan, A. Blei, K. Grüngreiff, R. Jalan, G. Kircheis… in Metabolic Brain Disease (2007)

  7. No Access

    Article

    Attention, Memory, and Cognitive Function in Hepatic Encephalopathy

    Deficits in attention and arousal play a major role in the clinical presentation of hepatic encephalopathy. Attention deficits arealso the main components of minimal hepatic encephalopathy. The present paper s...

    Karin Weissenborn, Kathrin Giewekemeyer, Susanne Heidenreich… in Metabolic Brain Disease (2005)

  8. No Access

    Article

    Preface

    Michael P. Manns, Karin Weissenborn in Metabolic Brain Disease (2004)

  9. No Access

    Article

    Functional Imaging of the Brain in Patients with Liver Cirrhosis

    Brain imaging techniques have provided substantial insight into the pathophysiology of hepatic encephalopathy (HE). Magnetic resonance imaging gave hint to the fact that there is an increased deposition of man...

    Karin Weissenborn, Martin Bokemeyer, Björn Ahl… in Metabolic Brain Disease (2004)

  10. No Access

    Article

    Correlations Between Cerebral Glucose Metabolism and Neuropsychological Test Performance in Nonalcoholic Cirrhotics

    Many cirrhotics have abnormal neuropsychological test scores. To define the anatomical–physiological basis for encephalopathy in nonalcoholic cirrhotics, we performed resting-state fluorodeoxyglucose positron ...

    Alan H. Lockwood, Karin Weissenborn, Martin Bokemeyer, U. Tietge… in Metabolic Brain Disease (2002)

  11. No Access

    Article

    Attention Deficits in Minimal Hepatic Encephalopathy

    Minimal hepatic encephalopathy (HE) is characterized by a decrease of psychomotor speed, and deficits in visual perception, visuo-spatial orientation, and visuo-constructive abilities. Attention deficits have ...

    Karin Weissenborn, Susanne Heidenreich, Jochen Ennen… in Metabolic Brain Disease (2001)

  12. No Access

    Article

    Altered Striatal Dopamine D2 Receptor Density and Dopamine Transport in a Patient with Hepatic Encephalopathy

    A patient suffering from liver cirrhosis presented with a bradykinetic-rigid syndrome suspected as Parkinson's disease. A detailed work-up of the case revealed hepatic encephalopathy as the cause of the neurol...

    Karin Weissenborn, Georg Berding, Herbert Köstler in Metabolic Brain Disease (2000)

  13. No Access

    Article

    Altered striatal dopamine D2 receptor density and dopamine transport in a patient with hepatic encephalopathy

    A patient suffering from liver cirrhosis presented with a bradykinetic-rigid syndrome suspected as Parkinson's disease. A detailed work-up of the case revealed hepatic encephalopathy as the cause of the neurol...

    Karin Weissenborn, Georg Berding, Herbert Köstler in Metabolic Brain Disease (2000)

  14. No Access

    Article

    Pathophysiology of Hepatic Encephalopathy: Results of the Hannover Consensus Conference

    Karin Weissenborn in Metabolic Brain Disease (1998)

  15. No Access

    Article

    The Basal Ganglia and Portal-Systemic Encephalopathy

    Despite decades of research, the pathogenesis of portal-systemic encephalopathy (PSE) remains puzzling. Current hypotheses on the pathophysiology of PSE usually deal with metabolic toxins like ammonia or distu...

    Karin Weissenborn, Hans Kolbe in Metabolic Brain Disease (1998)